Medtronic Launches PulseSelect™ Cardiac Technology in India, Claiming Breakthrough Performance

Medtronic introduced its PulseSelect™ cardiac technology in India. The device is marketed as a breakthrough in heart‑failure treatment. PulseSelect™ combines advanced pacing with diagnostic capabilities. Medtronic highlighted its potential to improve patient outcomes. The launch aligns with the company’s expansion strategy in Asia. Indian cardiologists will evaluate the technology in clinical settings. The rollout follows regulatory approval by Indian health authorities. Medtronic expects the product to set new standards for cardiac care in the region.